CN Bio unveils integrated organ-on-a-chip platform for drug discovery
Cambridge-based CN Bio has launched PhysioMimix Core, an organ-on-a-chip system designed to streamline drug development workflows by integrating multiple experimental configurations within a single microphysiological platform. The release marks a significant development in reducing animal model dependency whilst improving clinical translation of preclinical data.


